Abstract
Discussion Forum (0)
Introduction: To implement a group B streptococcus (GBS) self-swabbing protocol at The Women's Institute and to determine patient satisfaction in self-swabbing. Secondarily, to confirm physician and patient-collected swabs yield similar rates of GBS colonization.
Methods: This is a prospective quality project. Patients were provided the option to self-swab for GBS at their 35 to 37 week visit from January 3 to July 12, 2019. The patient was consented and educated on how to perform the swab. They then completed a short, three question survey to evaluate comfort and satisfaction. A retrospective chart review was performed from September 1, 2018 to July 12, 2019 to determine GBS colonization rates of provider-collected swabs.
Results: The rate of GBS colonization in patient-collected swabs was 14/67 (20.9%). Most patients felt comfortable performing the swab (92.5% CI 83.4 - 97.5%), felt educated in how to perform the swab (98.5% CI 92.0 - 100.0%), and either preferred to self-swab or had no preference of who performed future swabs (94.0% CI 85.4 - 98.4%). A retrospective chart review determined the rate of GBS colonization to be 47/238 (19.8%) in provider-collected swabs, which was not significantly different (19.8 vs 20.9, P .86) from patient-collected swabs.
Conclusion/Implications: The rate of GBS colonization between patient and provider-collected swabs was not significantly different, which is consistent with prior studies. Survey results demonstrated patient satisfaction and comfort performing the self-swab. This study supports providing our patients the option of self-swabbing for GBS.
Methods: This is a prospective quality project. Patients were provided the option to self-swab for GBS at their 35 to 37 week visit from January 3 to July 12, 2019. The patient was consented and educated on how to perform the swab. They then completed a short, three question survey to evaluate comfort and satisfaction. A retrospective chart review was performed from September 1, 2018 to July 12, 2019 to determine GBS colonization rates of provider-collected swabs.
Results: The rate of GBS colonization in patient-collected swabs was 14/67 (20.9%). Most patients felt comfortable performing the swab (92.5% CI 83.4 - 97.5%), felt educated in how to perform the swab (98.5% CI 92.0 - 100.0%), and either preferred to self-swab or had no preference of who performed future swabs (94.0% CI 85.4 - 98.4%). A retrospective chart review determined the rate of GBS colonization to be 47/238 (19.8%) in provider-collected swabs, which was not significantly different (19.8 vs 20.9, P .86) from patient-collected swabs.
Conclusion/Implications: The rate of GBS colonization between patient and provider-collected swabs was not significantly different, which is consistent with prior studies. Survey results demonstrated patient satisfaction and comfort performing the self-swab. This study supports providing our patients the option of self-swabbing for GBS.
Introduction: To implement a group B streptococcus (GBS) self-swabbing protocol at The Women's Institute and to determine patient satisfaction in self-swabbing. Secondarily, to confirm physician and patient-collected swabs yield similar rates of GBS colonization.
Methods: This is a prospective quality project. Patients were provided the option to self-swab for GBS at their 35 to 37 week visit from January 3 to July 12, 2019. The patient was consented and educated on how to perform the swab. They then completed a short, three question survey to evaluate comfort and satisfaction. A retrospective chart review was performed from September 1, 2018 to July 12, 2019 to determine GBS colonization rates of provider-collected swabs.
Results: The rate of GBS colonization in patient-collected swabs was 14/67 (20.9%). Most patients felt comfortable performing the swab (92.5% CI 83.4 - 97.5%), felt educated in how to perform the swab (98.5% CI 92.0 - 100.0%), and either preferred to self-swab or had no preference of who performed future swabs (94.0% CI 85.4 - 98.4%). A retrospective chart review determined the rate of GBS colonization to be 47/238 (19.8%) in provider-collected swabs, which was not significantly different (19.8 vs 20.9, P .86) from patient-collected swabs.
Conclusion/Implications: The rate of GBS colonization between patient and provider-collected swabs was not significantly different, which is consistent with prior studies. Survey results demonstrated patient satisfaction and comfort performing the self-swab. This study supports providing our patients the option of self-swabbing for GBS.
Methods: This is a prospective quality project. Patients were provided the option to self-swab for GBS at their 35 to 37 week visit from January 3 to July 12, 2019. The patient was consented and educated on how to perform the swab. They then completed a short, three question survey to evaluate comfort and satisfaction. A retrospective chart review was performed from September 1, 2018 to July 12, 2019 to determine GBS colonization rates of provider-collected swabs.
Results: The rate of GBS colonization in patient-collected swabs was 14/67 (20.9%). Most patients felt comfortable performing the swab (92.5% CI 83.4 - 97.5%), felt educated in how to perform the swab (98.5% CI 92.0 - 100.0%), and either preferred to self-swab or had no preference of who performed future swabs (94.0% CI 85.4 - 98.4%). A retrospective chart review determined the rate of GBS colonization to be 47/238 (19.8%) in provider-collected swabs, which was not significantly different (19.8 vs 20.9, P .86) from patient-collected swabs.
Conclusion/Implications: The rate of GBS colonization between patient and provider-collected swabs was not significantly different, which is consistent with prior studies. Survey results demonstrated patient satisfaction and comfort performing the self-swab. This study supports providing our patients the option of self-swabbing for GBS.
Implementation of GBS Self-Swabbing Protocol at The Women's Institute at Banner University Medical Center - Phoenix
Molly Gilbert
Abstract
Discussion Forum (0)
Introduction: To implement a group B streptococcus (GBS) self-swabbing protocol at The Women's Institute and to determine patient satisfaction in self-swabbing. Secondarily, to confirm physician and patient-collected swabs yield similar rates of GBS colonization.
Methods: This is a prospective quality project. Patients were provided the option to self-swab for GBS at their 35 to 37 week visit from January 3 to July 12, 2019. The patient was consented and educated on how to perform the swab. They then completed a short, three question survey to evaluate comfort and satisfaction. A retrospective chart review was performed from September 1, 2018 to July 12, 2019 to determine GBS colonization rates of provider-collected swabs.
Results: The rate of GBS colonization in patient-collected swabs was 14/67 (20.9%). Most patients felt comfortable performing the swab (92.5% CI 83.4 - 97.5%), felt educated in how to perform the swab (98.5% CI 92.0 - 100.0%), and either preferred to self-swab or had no preference of who performed future swabs (94.0% CI 85.4 - 98.4%). A retrospective chart review determined the rate of GBS colonization to be 47/238 (19.8%) in provider-collected swabs, which was not significantly different (19.8 vs 20.9, P .86) from patient-collected swabs.
Conclusion/Implications: The rate of GBS colonization between patient and provider-collected swabs was not significantly different, which is consistent with prior studies. Survey results demonstrated patient satisfaction and comfort performing the self-swab. This study supports providing our patients the option of self-swabbing for GBS.
Methods: This is a prospective quality project. Patients were provided the option to self-swab for GBS at their 35 to 37 week visit from January 3 to July 12, 2019. The patient was consented and educated on how to perform the swab. They then completed a short, three question survey to evaluate comfort and satisfaction. A retrospective chart review was performed from September 1, 2018 to July 12, 2019 to determine GBS colonization rates of provider-collected swabs.
Results: The rate of GBS colonization in patient-collected swabs was 14/67 (20.9%). Most patients felt comfortable performing the swab (92.5% CI 83.4 - 97.5%), felt educated in how to perform the swab (98.5% CI 92.0 - 100.0%), and either preferred to self-swab or had no preference of who performed future swabs (94.0% CI 85.4 - 98.4%). A retrospective chart review determined the rate of GBS colonization to be 47/238 (19.8%) in provider-collected swabs, which was not significantly different (19.8 vs 20.9, P .86) from patient-collected swabs.
Conclusion/Implications: The rate of GBS colonization between patient and provider-collected swabs was not significantly different, which is consistent with prior studies. Survey results demonstrated patient satisfaction and comfort performing the self-swab. This study supports providing our patients the option of self-swabbing for GBS.
Introduction: To implement a group B streptococcus (GBS) self-swabbing protocol at The Women's Institute and to determine patient satisfaction in self-swabbing. Secondarily, to confirm physician and patient-collected swabs yield similar rates of GBS colonization.
Methods: This is a prospective quality project. Patients were provided the option to self-swab for GBS at their 35 to 37 week visit from January 3 to July 12, 2019. The patient was consented and educated on how to perform the swab. They then completed a short, three question survey to evaluate comfort and satisfaction. A retrospective chart review was performed from September 1, 2018 to July 12, 2019 to determine GBS colonization rates of provider-collected swabs.
Results: The rate of GBS colonization in patient-collected swabs was 14/67 (20.9%). Most patients felt comfortable performing the swab (92.5% CI 83.4 - 97.5%), felt educated in how to perform the swab (98.5% CI 92.0 - 100.0%), and either preferred to self-swab or had no preference of who performed future swabs (94.0% CI 85.4 - 98.4%). A retrospective chart review determined the rate of GBS colonization to be 47/238 (19.8%) in provider-collected swabs, which was not significantly different (19.8 vs 20.9, P .86) from patient-collected swabs.
Conclusion/Implications: The rate of GBS colonization between patient and provider-collected swabs was not significantly different, which is consistent with prior studies. Survey results demonstrated patient satisfaction and comfort performing the self-swab. This study supports providing our patients the option of self-swabbing for GBS.
Methods: This is a prospective quality project. Patients were provided the option to self-swab for GBS at their 35 to 37 week visit from January 3 to July 12, 2019. The patient was consented and educated on how to perform the swab. They then completed a short, three question survey to evaluate comfort and satisfaction. A retrospective chart review was performed from September 1, 2018 to July 12, 2019 to determine GBS colonization rates of provider-collected swabs.
Results: The rate of GBS colonization in patient-collected swabs was 14/67 (20.9%). Most patients felt comfortable performing the swab (92.5% CI 83.4 - 97.5%), felt educated in how to perform the swab (98.5% CI 92.0 - 100.0%), and either preferred to self-swab or had no preference of who performed future swabs (94.0% CI 85.4 - 98.4%). A retrospective chart review determined the rate of GBS colonization to be 47/238 (19.8%) in provider-collected swabs, which was not significantly different (19.8 vs 20.9, P .86) from patient-collected swabs.
Conclusion/Implications: The rate of GBS colonization between patient and provider-collected swabs was not significantly different, which is consistent with prior studies. Survey results demonstrated patient satisfaction and comfort performing the self-swab. This study supports providing our patients the option of self-swabbing for GBS.
{{ help_message }}
{{filter}}